Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT03541096

Winter-Swimming and Brown Adipose Tissue Activity in Middel-aged Obese Subjects (WinterBAT).

This study investigates repetitive cold-water exposure on brown fat activity assessed by PET/CT scanning. Furthermore we will assess glucose control upon winter-swimming. Obese prediabetic men and women will be randomized to winter-swimming or control conditions for 4 months.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

About this study

Brown fat (BAT) is an energy-consuming tissue. Long-term activation of BAT in adults increases clearance of blood glucose and non-esterified fatty acids (NEFA), insulin sensitivity and metabolic rate. Moreover, adipokines released from BAT, known as batokines, represent a promising but currently unexplored area in terms of metabolic regulation. Cooling activates BAT; however, current cooling protocols fail to activate BAT in a large part of the population. Whether this failure in activation is related to biology, inefficient detection or cooling protocols is unknown. With our initial acute cooling study (protocol number: H-16038581), these protocols have successfully been optimized whereupon novel batokines will be identified. Having established a methodology for assessing BAT activity and batokine profiles, a longer-term cooling intervention (winter swimming) will be performed to examine the effect of repetitive cold-water exposure on BAT activity. Obese pre-diabetic subjects will be included in a 4-month supervised winter swimming (WS) intervention.

It is hypothesized, that repetitive cold-water exposure constituted by WS, increase BAT activation and volume, followed by improved glycemic control in obese pre-diabetic subjects.

Method The study is a randomized controlled, parallel-group intervention study. The investigator will recruit 30 obese pre-diabetic non-winter-swimmers to participate in a WS intervention group (n=15) or control group (n=15) with no WS activities. Subjects will either be randomized to the WS group, who will winter-swim 4 months, 2-3 times/week including sauna-visits if desired, or control conditions with no WS during the 4 months (October to May).

Main aims

  • To assess whether WS will have an immediate effect on BAT recruitment or function.
  • To assess whether WS will have an effect on glycemic control.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Waist circumference above 80 cm for women and 94 cm for men.
  • BMI > 25 but <40 kg/m2
  • Age > 40 years.
  • Low to moderate physical activity level (no physical activity or on average 30 minutes of moderate physical activity per day and not more than 3 hours of training pr. Week)

Subjects will be included in either one of these cases after the screening:

  • Fasting plasma glucose above 5.6 millimol per liter (mmoL/L).
  • HbA1C >39 millimol per mol (mmol/mol).
  • 2 hour plasma glucose after a 75 g. oral glucose tolerance test (OGTT) above 7.8 mmol/L.

Exclusion criteria

  • Winter swimmer
  • Any history of Cancer,
  • Clinically significant liver, kidney, heart, inflammatory or lung-disease.
  • Pregnancy
  • Taking medication (not for hay fever), including glucose-lowering treatment.
  • HbA1c >55 mmol/mol and/or 2-h plasma glucose in the 75-g OGTT > 15 mmol/L, fasting plasma glucose above 6.9.
  • Iron deficiency
  • Increased International Normalised Ratio for coagulation (INR).
  • Femoral hernia, vene prostheses (pants prosthesis), thrombs in v. Femoralis.
  • Abnormal ultrasound echocardiography of the heart found at the health-examination day.
  • Contraindications to cold exposure including severe Raynauds disease.
  • History of alcohol abuse or use of more than 14 units pr. Week.
  • History of drug abuse, including marihuana.
  • Smoking including occasional smoking.
  • Pacemaker or other electronics implanted in the body.
  • Claustrophobia, communication problems, including understanding the experimental protocol.
  • History of contrast allergy.

Treatment and study plan

Winter Swimming

Behavioral

Supervised Winter Swimming in Copenhagen

Control Group

Behavioral

No winter swimming activities.

Primary outcomes

  1. Difference between groups in change in brown adipose tissue (BAT) activity during cooling

    Time frame: Day 0 (before intervention) and Day 120 (after intervention)

    BAT activity is measured using positron emission tomography (PET)- Computer tomography (CT) scan. The PET-CT scan uses a glucose-radiotracer (fludeoxyglucose-18 (FDG)) to measure the glucose uptake in BAT, which is associated with BAT activity. FDG is injected following one hour of cooling and the subjects are scanned following one additional hour of cooling. The subjects are continuously cooled throughout the scanning procedure. Difference between groups in change in FDG tracer uptake (post minus pre intervention) during 1,5 hours of cooling is calculated.

Secondary outcomes

  1. Difference between groups in change in glycemic control

    Time frame: Day 0 (before intervention) and Day 120 (after intervention)

    Glycemic control is measured using a 4 hour mixed meal tolerance test. Difference between groups in change in the mean MMTT glucose levels during the MMTT (post minus pre intervention) will be calculated.

Sponsors and collaborators

Lead sponsor

Kristian Karstoft

Other

Registry information

Official study title

The Impact of Winter Swimming on Brown Adipose Tissue Recruitment and Metabolic Health in Middel-aged Obese Pre-diabetic Subjects.

Acronym: WinterBAT

Important dates

Study start
2018
Primary completion
2021
Study completion
2025
First posted
May 30, 2018
Registry last updated
Aug 17, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.